Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy by Hill, Brian T., Roth, Caroline J, Kositsky, Rachel, Dave, Tushar, Love, Cassandra, McKinney, Matthew, Galal, Ahmed, Neff, Jadee L, Mian, Agrima, Kendall, Ellen, Ondrejka, Sarah L., Chiaramonte, Matthew, Bhagat, Govind, Ofori, Kenneth, Reshef, Ran, Kovach, Alexandra E., Sethi, Tarsheen, Mason, Emily F, Bhaskar, Shakthi, Oluwole, Olalekan O., Pallas, Christopher, Ghosh, Nilanjan, Ferdman, Robert, Chen, George L., Hernandez-Ilizaliturri, Francisco J., Zurko, Joanna C., Cunningham, Ashley, Shah, Nirav N., Hu, Boyu, Stephens, Deborah M., Ghosh, Monalisa, Bailey, Neil, Patel, Krish, Pagel, John M., Kannan, Kavya Kannamma, Hsi, Eric D., Vaidya, Rakhee, Ip, Andrew, Goy, Andre H., Kambhampati, Swetha, Ohgami, Robert S., Andreadis, Charalambos, Thacker, Elizabeth, Rozzi, Chrissie, Parker, Clay, Happ, Lanie, Dave, Sandeep S.

Get full text